Fletazepam
From Wikipedia, the free encyclopedia
Fletazepam
|
|
Systematic (IUPAC) name | |
7-chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-2,3-dihydro-1,4-benzodiazepine | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C17H13ClF4N2 |
Mol. mass | 356.745 |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Fletazepam is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, but is mainly notable for its strong muscle relaxant properties.[1]
Fletazepam is most closely related to other N-trifluoroethyl substituted benzodiazepines such as halazepam and quazepam.[2]
[edit] References
- ^ Barnett A, Goldstein J, Fiedler EP, Taber RI. The pharmacology of fletazepam, a centrally-acting muscle relaxant. Archives Internationales de Pharmacodynamie et de Therapie. 1974 Nov;212(1):164-74.
- ^ Orio LC, Barnett A, Billard W. Selective affinity of 1-N-trifluoroethyl benzodiazepines for cerebellar type 1 receptor sites. Life Sciences, 1984. (35):105-113.
|